// App-Quantinova.ai

1514 : Phase II Trial of Clofarabine in Combination with Topotecan, Vinorelbine, and Thiotepa (TVTC) in Pediatric Patients with Refractory or Relapsed Acute Leukemia

Researchers

Presenter

  • Rachel Kobos

Principal Investigators

  • Thomas M. Renaud

  • Laurel Steinherz

  • Peter G Steinherz

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

  • Acute Leukemia

  • Cardiac arrest

  • Neutropenia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Clofarabine

  • Gemcitabine

  • Vinorelbine

  • Topotecan Hydrochloride

  • Thiotepa

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved